Attovia Therapeutics, Inc. ($ATTO)
Filing Information
| Accession Number | 0001231919-26-000838 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 6, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
57,086,820
Total Value
$9,999,995.00
P&L
+18.6% (+$1,864,704.95)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Aug 6, 2026 | Conversion | 1,749,192 | โ | โ | 1,824,541 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Conversion | 1,590,175 | โ | โ | 3,414,716 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Conversion | 1,189,940 | โ | โ | 4,604,656 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Conversion | 961,322 | โ | โ | 5,565,978 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Purchase | 588,235 | $17.00 | $9,999,995.00 | 6,154,213 | Direct | โ | View Details | |
10% Owner | Series A-1 Preferred Stock | Derivative | Aug 6, 2026 | Conversion | 16,250,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series A-2 Preferred Stock | Derivative | Aug 6, 2026 | Conversion | 14,772,727 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series B Preferred Stock | Derivative | Aug 6, 2026 | Conversion | 11,054,544 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series C Preferred Stock | Derivative | Aug 6, 2026 | Conversion | 8,930,685 | $0.00 | $0.00 | 0 | Direct | โ | View Details |